| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | | Total Revenue | 1,545 | 1,718 | | Cost of Revenue | 2,814 | 1,131 | | | Gross Profit | (1,268) | 588 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 100 | 49 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (1,369) | 539 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (73,758) | (10,631) | | Earnings Before Interest And Taxes | (1,369) | 539 | | Interest Expense |
-
|
-
| | Income Before Tax | (1,369) | 539 | | Income Tax Expense | 4 |
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (75,130) | (10,092) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (75,130) | (10,092) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($75,130) | ($10,092) |
|
0.01% Nasdaq 
0.22%
Income Statement
